working

Sign up for free to access

Get access to the latest equity research in real-time from 12 commissioned providers.

Get access to the latest equity research in real-time from 12 commissioned providers.


Get Started
Already a member? Log in here

More Content

More Content

Newron Pharmaceuticals:Phase III ENIGMA-TRS 2 trial underway

Companies: Newron Pharmaceuticals S.p.A.

Newron Pharmaceuticals – EKF interview

Companies: Newron Pharmaceuticals S.p.A.

Webinar: The CNS renaissance Biotech companies at the forefront

Companies: Herantis Pharma Plc (HRTIS:HEL)Newron Pharmaceuticals S.p.A. (NWRN:SWX)

Newron Pharmaceuticals - Schizophrenia development adds value

Companies: Newron Pharmaceuticals S.p.A.

Newron Pharmaceuticals:H125 results reflect evenamide progress

Companies: Newron Pharmaceuticals S.p.A.

© Research Tree 2026

  • Apple Store
  • Play Store

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top